VIP modulates intracellular calcium oscillations in human lymphoblasts

Area of Science:

• Cellular and Molecular Physiology
• Neuroendocrinology
• Calcium Signaling

Background:

• Vasoactive intestinal polypeptide (VIP) is known to stimulate adenylate cyclase in MOLT 4 lymphoblasts.
• The precise mechanisms by which VIP influences cellular functions, particularly calcium homeostasis, require further elucidation.

Purpose of the Study:

• To investigate whether VIP modulates intracellular calcium concentrations ([Ca2+]i) in MOLT 4 lymphoblasts.
• To determine if VIP's modulation of [Ca2+]i is mediated by the adenylate cyclase pathway.

Main Methods:

• Monitoring of intracellular calcium ([Ca2+]i) using fura-2 fluorescence in single MOLT 4 lymphoblasts and cell suspensions.
• Assessment of VIP's effect on [Ca2+]i oscillations, amplitude, frequency, and response to pharmacological agents (La3+, KCl, dibutyryl cyclic AMP, forskolin).

Main Results:

• A subset of MOLT 4 cells exhibited spontaneous, La(3+)-sensitive intracellular calcium oscillations.
• VIP dose-dependently increased the amplitude of these [Ca2+]i oscillations but not their frequency, an effect observed at concentrations below the VIP receptor KD.
• Neither dibutyryl cyclic AMP nor forskolin affected [Ca2+]i oscillations, indicating the absence of adenylate cyclase mediation.

Conclusions:

• VIP modulates the amplitude of intracellular calcium oscillations in a subset of lymphoblasts via a mechanism independent of adenylate cyclase.
• Baseline [Ca2+]i levels may correlate with the capacity for spontaneous oscillations and responsiveness to VIP.
• VIP-induced [Ca2+]i changes are cell-specific and not detectable in bulk cell suspensions due to the limited number of responding cells.